Approaches to mitochondrial gene therapy

Current Gene Therapy

Volumn 4, Issue 3, 2004, Pages 317-328

  D'Souza, Gerard G M ^a   Weissig, Volkmar ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; DNA GLYCOSYLTRANSFERASE; DRUG CARRIER; MITOCHONDRIAL DNA; OLIGONUCLEOTIDE; PEPTIDE NUCLEIC ACID; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; RESTRICTION ENDONUCLEASE;

AEROBIC METABOLISM; DNA DEGRADATION; DNA REPAIR; DNA VECTOR; DRUG DNA BINDING; DRUG MECHANISM; GENE CONSTRUCT; GENE DELIVERY SYSTEM; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC CODE; GENETIC TRANSFECTION; HUMAN; MITOCHONDRIAL DNA DISORDER; MOLECULAR WEIGHT; NONHUMAN; REVIEW;

EID: 4444334765     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/1566523043346200     Document Type: Review

References (94)

1. Allen, J.F. (2003) The function of genomes in bioenergetic organelles. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 358: (1429) 19-37; discussion 37-8.
2. Attardi, G.M. (2001) Role of mitochondrial DNA in aging processes. Scientific World Journal, 1: (1 Suppl. 3) 76.
3. Bandyopadhyay, P., Ma, X., Linehan-Stieers, C., Kren, B.T. and Steer, C.J. (1999) Nucleotide exchange in genomic DNA of rat hepatocytes using RNA/DNA oligonucleotides. Targeted delivery of liposomes and polyethyleneimine to the asialoglycoprotein receptor. J. Biol. Chem., 274: (15) 10163-72.
4. Bigger, B.W., Tolmachov, O., Collombet, J.M., Fragkos, M., Palaszewski, I. and Coutelle, C. (2001) An araC-controlled bacterial ere expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy. J. Biol. Chem., 276: (25) 23018-27.
5. Boussif, O., Lezoualc'h, F., Zanta, M.A., Mergny, M.D., Scherman, D., Demeneix, B. and Behr, J.P. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA, 92: (16) 7297-301.
6. Butow, R.A. and Fox, T.D. (1990) Organelle transformation: shoot first, ask questions later. Trends Biochem Sci., 15: (12) 465-8.
7. Butow, R.A., Henke, R.M., Moran, J.V., Belcher, S.M. and Perlman, P.S. (1996) Transformation of Saccharomyces cerevisiae mitochondria using the biolistic gun. Methods Enzymol., 264: 265-78.
8. Chen, Z., Felsheim, R., Wong, P., Augustin, L.B., Metz, R., Kren, B.T. and Steer, C.J. (2001) Mitochondria isolated from liver contain the essential factors required for RNA/DNA oligonucleotide-targeted gene repair. Biochem. Biophys. Res. Commun., 285: (2) 188-94.
9. Chinnery, P.F., Taylor, R.W., Dickert, K., Lill, R., Turnbull, D.M. and Lightowlers, R.N. (1999) Peptide nucleic acid delivery to human mitochondria. Gene Ther., 6: (12) 1919-28.
10. Chomyn, A., Martinuzzi, A., Yoneda, M., Daga, A., Hurko, O., Johns, D., Lai, S.T., Nonaka, I, Angelini, C. and Attardi, G. (1992) MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc. Natl. Acad. Sci. USA, 89: (10) 4221-5.
11. Chrzanowska-Lightowlers, Z.M., Temperley, R.J., McGregor, A., Bindoff, L.A. and Lightowlers, R.N. (1999) Conversion of a reporter gene for mitochondrial gene expression using iterative mega-prime PCR. Gene, 230: (2) 241-7.
12. Collombet, J.M., Wheeler, V.C., Vogel, F. and Coutelle, C. (1997) Introduction of plasmid DNA into isolated mitochondria by electroporation. A novel approach toward gene correction for mitochondrial disorders. J. Biol. Chem., 272: (8) 5342-7.
13. de Grey, A.D. (2000) Mitochondrial gene therapy: all arena for the biomedical use of inteins. Trends Biotechnol., 18: (9) 394-9.
14. De Vivo, D.C. (1993) Mitochondrial DNA defects: Clinical features. Mitochondrial DNA in human pathology, S. a. W. DiMauro, D.C., Eds., Raven Press, New York, 39-52.
15. Druzhyna, N.M., Hollensworth, S.B., Kelley, M.R., Wilson, G.L. and Ledoux, S.P. (2003) Targeting human 8-oxoguanine glycosylase to mitochondria of oligodendrocytes protects against menadione-induced oxidative stress. Glia., 42: (4) 370-8.
16. D'Souza, G.G., Rammohan, R., Cheng, S.M., Torchilin, V.P. and Weissig, V. (2003) DQAsome-mediated delivery of' plasmid DNA toward mitochondria in living cells. J. Control Release, 92: (1-2) 189-97.
17. Entelis, N.S., Kieffer, S., Kolesnikova, O.A., Martin, R.P. and Tarassov, I.A. (1998) Structural requirements of tRNALys for its import into yeast mitochondria. Proc. Natl. Acad. Sci. USA, 95: (6) 2838-43.
18. Entelis, N.S., Kolesnikova, O.A., Dogan, S., Martin, R.P. and Tarassov, I.A. (2001) 5 S rRNA and tRNA import into human mitochondria. Comparison of in vitro requirements. J. Biol. Chem., 276: (49) 45642-53.
19. Flierl, A., Jackson, C., Cottrell, B., Murdock, D., Seibel, P. and Wallace, D.C. (2003) Targeted delivery of DNA to the mitochondrial compartment via import sequence-conjugated peptide nucleic acid. Mol. Ther., 7: (4) 550-7.
20. Gergoriadis, G. and McCormack, B., Eds. (2000). Targeting of Drugs; Strategies for gene constructs and delivery. Amsterdam, IOS Press.
21. Geromel, V., Cao, A., Briane, D., Vassy, J., Rotig, A., Rustin, P., Coudert, R., Rigaut, J.P., Munnich, A. and Taillandier, E. (2001) Mitochondria transfection by oligonucleotides containing a signal peptide and vectorized by cationic liposomes. Antisense Nucleic Acid Drug Dev., 11: (3) 175-80.
22. Hanna, M.G., Nelson, I.P., Morgan-Hughes, J.A. and Harding, A.E. (1995) Impaired mitochondrial translation in human myoblasts harbouring the mitochondrial DNA tRNA lysine 8344 A-->G (MERRF) mutation: relationship to proportion of mutant mitochondrial DNA. J. Neurol. Sci., 130: (2) 154-60.
23. Harding, A.E. (1991) Neurological disease and mitochondrial genes. Trends Neurosci., 14: (4) 132-8.
24. Holt, I.J., Harding, A.E. and Morgan-Hughes, J.A. (1988) Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature, 331: (6158) 717-9.
25. Hoogenraad, N.J., Ward, L.A. and Ryan, M.T. (2002) Import and assembly of proteins into mitochondria of mammalian cells. Biochim. Biophys, Acta, 1592: (1) 97-105.
26. Inoue, K., Nakada, K., Ogura, A., Isobe, K., Goto, Y., Nonaka, I. and Hayashi, J.I. (2000) Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes. Nat. Genet., 26: (2) 176-81.
27. Inoue, K., Ogura, A. and Hayashi, J. (2002) Production of mitochondrial DNA transgenic mice using zygotes. Methods, 26: (4) 358-63.
28. Jacobs, H.T. (1991) Structural similarities between a mitochondrially encoded polypeptide and a family of prokaryotic respiratory toxins involved in plasmid maintenance suggest a novel mechanism for the evolutionary maintenance of mitochondrial DNA. J. Mol. Evol., 32: (4) 333-9.
29. James, A.M., Blaikie, F.H., Smith, R.A., Lightowlers, R.N., Smith, P.M. and Murphy, M.P. (2003) Specific targeting of a DNA-alkylating reagent to mitochondria. Synthesis and characterization of [4-(11aS -7-methoxy-1,2,3,11a-tetrahydro-511-pyrrolo[2,1-c][1,4]benzodiaze pin-5-on-8-oxy)butyl]-triphenylphosphonium iodide. Eur. J Biochem., 270: (13) 2827-36.
30. Jauslin, M.L., Meier, T., Smith, R.A. and Murphy, M.P. (2003) Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J.
31. Jazayeri, M., Andreyev, A., Will, Y., Ward, M., Anderson, C.M. and Clevenger, W. (2003) Inducible expression of a dominant negative DNA polymerase-gamma depletes mitochondrial DNA and Produces a rho0 phenotype. J. Biol. Chem., 278: (11) 9823-30.
32. Johnston, S.A., Anziano, P.Q., Shark, K., Sanford, J.C. and Butow, R.A. (1988) Mitochondrial transformation in yeast by bombardment with microprojectiles. Science, 240: (4858) 1538-41.
33. Kagawa, Y. and Hayashi, J.I. (1997) Gene therapy of mitochondrial diseases using human cytoplasts. Gene Ther.. 4: (1) 6-10.
34. Kagawa, Y., Inoki, Y. and Endo, H. (2001) Gene therapy by mitochondrial transfer. Adv. Drug Deliv. Rev., 49: (1-2) 107-19.
35. Kazakova, H.A., Entelis, N.S., Martin, R.P. and Tarassov, I.A. (1999) The aminoacceptor stein of the yeast tRNA(Lys) contains determinants of mitochondrial import selectivity. FEBS Lett., 442: (2-3) 193-7.
36. Kelso, G.F., Porteous, C.M., Coulter, C.V., Hughes, G., Porteous, W.K., Ledgerwood, E.C., Smith, R.A. and Murphy, M.P. (2001) Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J. Biol. Chem., 276: (7) 4588-96.
37. Kelso, G.F., Porteous, C.M., Hughes, G., Ledgerwood, F.C., Gane, A.M., Smith, R.A. and Murphy, M.P. (2002) Prevention of mitochondrial oxidative damage using targeted antioxidants. Ann. N. Y. Acad. Sci., 959: 263-74.
38. Kolesnikova, O.A., Entelis, N.S., Mireau, H., Fox, T.D., Martin, R.P. and Tarassov, I.A. (2000) Suppression of mutations in mitochondrial DNA by tRNAs imported from the cytoplasm. Science, 289: (5486) 1931-3.
39. Kren, B.T., Bandyopadhyay, P., Chowdhury, N.R., Chowdhury, J.R. and Steer, C.J. (2002a) Oligonucleotide-mediated site-directed gene repair. Methods Enzymol., 346: 14-35.
40. Kren, B.T., Chen, Z., Felsheim, R., Roy Chowdhury, N., Roy Chowdhury, J. and Steer, C.J. (2002b) Modification of hepatic genomic DNA using RNA/DNA oligonucleotides. Gene Ther., 9: (11) 686-90.
41. Kren, B.T., Cole-Strauss, A., Kmiec, E.B. and Steer, C.J. (1997) Targeted nucleotide exchange in the alkaline phosphatase gene of HuH-7 cells mediated by a chimeric RNA/DNA oligonucleotide. Hepatology, 25: (6) 1462-8.
42. Kren, B.T., Wong, P.Y. and Steer, C.J. (2003) Short, single-stranded oligonucleotides mediate targeted nucleotide conversion using extracts from isolated liver mitochondria. DNA Repair (Amst), 2: (5) 531-46.
43. Lacorazza, H.D. and Jendoubi, M. ( 1995) Correction of ornithine-delta-aminotransferase deficiency in a Chinese hamster ovary cell line mediated by retrovirus gene transfer. Gene Ther., 2: (1) 22-8.
44. Ledley, F.D. (1996) Pharmaceutical approach to somatic gene therapy. Pharm. Res., 13: (11) 1595-614.
45. Manfredi, G., Fu, J., Ojaimi, J., Sadlock, J.F., Kwong, J.Q., Guy, J. and Schon, E.A. (2002) Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus. Nat. Genet., 30: (4) 394-9.
46. Mason, P.A., Matheson, E.C., Hall, A.G. and Lightowlers, R.N. (2003) Mismatch repair activity in mammalian mitochondria. Nucleic Acids Res., 31: (3) 1052-8.
47. Mukhopadhyay, A., Heard, T.S., Wen, X., Hammen, P.K. and Weiner, H. (2003) Location of the actual signal in the negatively charged leader sequence involved in the import into the mitochondrial matrix space. J. Biol. Chem., 278: (16) 13712-8.
48. Munnich, A. and Rustin, P. (2001) Clinical spectrum and diagnosis of mitochondrial disorders. Am. J. Med. Genet., 106: (1) 4-17.
49. Muratovska, A., Lightowlers, R.N., Taylor, R.W., Turnbull, D.M., Smith, R.A., Wilce, J.A., Martin, S.W. and Murphy, M.P. (2001) Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease. Nucleic Acids Res., 29: (9) 1852-63.
50. Murphy, M.P. (1997) Selective targeting of bioactive compounds to mitochondria. Trends Biotechnol., 15: (8) 326-30.
51. Nagley, P. and Devenish, R.J. (1989) Leading organellar proteins along new pathways: the relocation of mitochondrial and chloroplast genes to the nucleus. Trends Biochem. Sci.. 14: 31-35.
52. Nakabeppu, Y. (2001) Regulation of intracellular localization of human MTH1, OGG1, and MYH proteins for repair of oxidative DNA damage. Prog. Nucleic Acid Res. Mol. Biol., 68: 75-94.
53. Neupert, W. (1997) Protein import into mitochondria. Annu. Rev. Biochem., 66: 863-917.
54. Owen, R.I., Lewin, A.P., Peel, A., Wang, J., Guy, J., Hauswirth, W.W., Stacpoole, P.W. and Flotte, T.R. (2000) Recombinant adeno-associated virus vector-based gene transfer for defects in oxidative metabolism. Hum. Gene Ther. 11: ( 15) 2067-78.
55. Owen, R.t. and Flotte, T.R. (2001) Approaches and limitations to gene therapy for mitochondrial diseases. Antioxid. Redox. Signal, 3: (3) 451-60.
56. Papa, S., Scacco, S., Schliebs, M., Trappe, J. and Seibel, P. (1996) Mitochondrial diseases and aging. Mol. Aspects Med, 17: (6) 513-63.
57. Pinkert, C.A., Irwin, M.H., Johnson, L.W. and Moffatt, R.J. (1997) Mitochondria transfer into mouse ova by microinjection. Transgenic Res., 6: (6) 379-83.
58. Pulkes, T. and Hanna, M.G. (2001) Human mitochondrial DNA diseases. Adv. Drug Deliv. Rev., 49: (1-2) 27-43.
59. Rachek, L.I., Grishko, V.I., Musiyenko, S.I., Kelley, M.R., LeDoux, S.P. and Wilson, G.L. (2002) Conditional targeting of the DNA repair enzyme hOGG1 into mitochondria. J. Biol. Chem., 277: (47) 44932-7.
60. Robin, E.D. and Wong, R. (1988) Mitochondrial DNA molecules and virtual number of mitochondria per cell in mammalian cells. J. Cell. Physiol., 136: (3) 507-13.
61. Rolland, A., Ed. (1999). Advanced gene delivery. Amsterdam, Harwood Academic.
62. Ross, G.F., Smith, P.M., McGregor, A., Turnbull, D.M. and Lightowlers, R.N. (2003) Synthesis of trifunctional PNA-benzophenone derivatives for mitochondrial targeting, selective DNA binding, and photo-cross-linking. Bioconjug. Chem., 14: (5) 962-6.
63. Satoh, M. and Kuroiwa, T. (199 1) Organization of multiple nucleoids and DNA molecules in mitochondria of a human cell. Exp. Cell. Res., 196: (1) 137-40.
64. Schatz, G. and Dobberstein, B. (1996) Common principles of protein translocation across membranes. Science, 271: (5255) 1519-26.
65. Scheffler, I.E. (1999) Evolutionary origin of mitochondria. Mitochondria, Wiley-Liss, New York, Chichester, Weinheim, Brisbane, Singapore, Toronto, 7-14.
66. Scheffler, I.E. (2001) Mitochondria make a come back. Adv. Drug Deliv. Rev., 49: (1-2) 3-26.
67. Seibel, P., Trappe, J., Villani, G., Klopstock, T., Papa, S. and Reichmann, H. (1995) Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases. Nucleic Acids Res., 23: (1) 10-7.
68. Smith, R.A., Porteous, C.M., Coulter, C.V. and Murphy, M.P. (1999) Selective targeting of an antioxidant to mitochondria. Eur. J. Biochem., 263: (3) 709-16.
69. Sobol, R.E. and Scanlon, K.J., Eds. (1995). The internet book of gene therapy. Stamford, CT, Appleton and Lange.
70. Solignac, M., Monnerot, M. and Mounolou, J.C. (1983) Mitochondrial DNA heteroplasmy in Drosophila mauritiana. Proc. Natl. Acad. Sci. USA, 80: (22) 6942-6.
71. Srivastava, S. and Moraes, C.T. (2001) Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonuclease. Hum. Mol. Genet. 10: (26) 3093-9.
72. Sullivan, S., Gong, Y. and Hughes, J. (2003) Cationic liposomes in gene delivery. Liposomes.. A Practical Approach, V. P. Torchilin and V. Weissig, Oxford University Press.
73. Tanaka, M., Borgeld, H.J., Zhang, J., Muramatsu, S., Gong, J.S., Yoneda, M., Maruyama, W., Naoi, M., Ibi, T., Sahashi, K., Shamoto, M., Fuku, N., Kurata, M., Yamada, Y., Nishizawa, K., Akao, Y., Ohishi, N., Miyabayashi, S., Umemoto, H., Muramatsu, T., Furukawa, K., Kikuchi, A., Nakano, L, Ozawa, K. and Yagi, K. (2002) Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria. J. Biomed Sci., 9: (6 Pt 1) 534-4 1.
74. Taylor, R.W., Chinnery, P.F., Turnbull, D.M. and Lightowlers, R.N. (1997) Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat. Genet., 15: (2) 212-5.
75. Taylor, R.W., Chinnery, P.F., Turnbull, D.M. and Lightowlers, R.N. (2000a) In-vitro genetic modification of mitochondrial function. Hum. Reprod, 15 Suppl 2: 79-85.
76. Taylor, R.W., Wardell, T.M., Lightowlers, R.N. and Turnbull, D.M. (2000b) Molecular basis for treatment of mitochondrial myopathies. Neurol. Sci., 21: (5 Suppl) S909-12.
77. Taylor, R.W., Wardell, T.M., Smith, P.M., Muratovska, A., Murphy, M.P., Turnbull, D.M. and Lightowlers, R.N. (2001 ) An antigenomic strategy for treating heteroplasmic mtDNA disorders. Adv. Drug Deliv. Rev., 49: (1-2) 121-5.
78. Thyagarajan, B., Padua, R.A. and Campbell, C. (1996) Mammalian mitochondria possess homologous DNA recombination activity. J. Biol. Chem, 271; (44) 27536-43.
79. Vestweber, D. and Schatz, G. (1989) DNA-protein conjugates can enter mitochondria via the protein import pathway. Nature, 338: (6211) 170-2.
80. Wallace, D.C. (1999) Mitochondrial diseases in man and mouse. Science, 283: (5407) 1482-8.
81. Wallace, D.C., Singh, G., Lott, M.T., Hodge, J.A., Schurr, T.G., Lezza, A.M., Elsas, L.J., 2nd and Nikoskelainen, E.K. (1988) Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science, 242: (4884) 1427-30.
82. Weissig, V., D'Souza, G.G. and Torchilin, V.P. (2001a) DQAsome/DNA complexes release DNA upon contact with isolated mouse liver mitochondria. J. Control Release, 75: (3) 401-8.
83. Weissig, V., Lizano, C., Ganellin, C.R. and Torchilin, V.P. (2001b) DNA binding cationic bolasomes with delocalized charge center. A structure-activity relationship study. S.T.P. Pharma Sciences, 11: (1) 91-96.
84. Weissig, V., Lizano, C. and Torchilin, V.P. (2000) Selective DNA release from DQAsome/DNA complexes at mitochondria-like membranes. Drug Deliv., 7: (1) 1-5.
85. Weissig, V. and Torchilin, V.P. (2001c) Cationic bolasomes with delocalized charge centers as mitochondria- specific DNA delivery systems. Adv. Drug Deliv. Rev., 49: (1-2) 127-49.
86. Weissig, V. and Torchilin, V.P. (2001d) Towards mitochondrial gene therapy: DQAsomes as a strategy. J. Drug Target. 9: (1) 1-13.
87. Wheeler, V.C., Aitken, M. and Coutelle, C. (1997) Modification of the mouse mitochondrial genome by insertion of an exogenous gene. Gene, 198: (1-2) 203-9.
88. Wheeler, V.C., Prodromou, C., Pearl, L.H., Williamson, R. and Coutelle, C. (1996) Synthesis of a modified gene encoding human ornithine transcarbamylase for expression in mammalian mitochondrial and universal translation systems: a novel approach towards correction of a genetic defect. Gene, 169: (2) 251-5.
89. Xu, Y. and Szoka, F.C., Jr. (1996) Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry. 35: (18) 5616-23.
90. Yoon, Y.G. and Koob, M.D. (2003) Efficient cloning and engineering of entire mitochondrial genomes in Escherichia coli and transfer into transcriptionally active mitochondria. Nucleic Acids Res., 31: (5) 1407-15.
91. Zabner, J., Fasbender, A.J., Moninger, T., Poellinger, K.A. and Welsh, M.J. (1995) Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem., 270: (32) 18997-9007.
92. Zanta, M.A., Belguise-Valladier, P. and Behr, J.P. (1999) Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. USA, 96: (1) 91-6.
93. Zimmer, K.P., Bendiks, M., Mori, M., Kominami, E., Robinson, M.B., Ye, X, and Wilson, J.M. (1999) Efficient mitochondrial import of newly synthesized ornithine transcarbamylase (OTC) and correction of secondary metabolic alterations in spf(ash) mice following gene therapy of OTC deficiency. Mol. Med, 5: (4) 244-53.
94. Zullo, S.J. (2001) Gene therapy of mitochondrial DNA mutations: a brief, biased history of allotopic expression in mammalian cells. Semin. Neural., 21: (3) 327-35.